ROCK2 and neurodegenerative disease: Increasing with age, ROCK2 activation has been linked to neuronal cell death in Alzheimer’s brain and other neurodegenerative diseases [90, 91] and might be a potential therapeutic target to retard the progressive neuronal loss [92].